These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6351429)

  • 1. [Modulating action of interferon preparations on cellular reactions of antitumor immunity].
    Mkrtchian LN; Ter-Pogosian ZR; Sarkisian OM; Gevorkian RA; Movsesian EA
    Vopr Onkol; 1983; 29(8):7-11. PubMed ID: 6351429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological response of patients with tumors of the urogenital tract: a follow-up of cell-mediated antitumor immunity by the LAI test.
    Holán V; Heyberger K; Bubeník J; Hasek M; Kanka J; Laurová L
    Neoplasma; 1977; 24(1):71-9. PubMed ID: 320490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunomodulating action of interferon preparations. The effect of medicinal alpha-interferon preparations on the rosette-forming activity of human blood lymphocytes].
    Avdeeva ZhI; Mazina NM; Lukasheva TV; Krylov OR; Kuznetsov VP; Medunitsyn NV
    Vestn Dermatol Venerol; 1990; (7):7-12. PubMed ID: 2256371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various immunological and immunomorphological changes in patients with breast cancer after interferon administration].
    Mkrtchian LN; Galstian AM; Ovanesbekova TG; Ter-Pogosian ZR; Kuznetsov VP
    Vopr Onkol; 1986; 32(10):25-31. PubMed ID: 3490716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic specificity and cellular mechanisms in leukocyte adherence inhibition analysis of immunity to simple proteins and hapten-protein conjugates.
    Powell A; Sloss AM; Smith RN; Murrell H
    Cancer Res; 1979 Feb; 39(2 Pt 2):570-5. PubMed ID: 83911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of specific immunoreactivity by LAI assay in patients with malignant melanoma of uveal tissue.
    Kalafut F; Cernák A; Pham Manh Hung
    Neoplasma; 1979; 26(3):299-305. PubMed ID: 394010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
    Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
    Kharkevich DD; Tabagari DZ; Savinov AIu
    Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of MS associated factors for test procedures in multiple sclerosis: 2. Angers' MS-induced substance in the LAI test].
    Lehmitz R; Meyer U; Meyer-Rienecker HJ
    Psychiatr Neurol Med Psychol (Leipz); 1983 Dec; 35(12):714-9. PubMed ID: 6366844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity in cervical cancer evolution.
    Jandová A; Pokorný J; Kobilková J; Janousek M; Masata J; Trojan S; Nedbalová M; Dohnalová A; Beková A; Slavík V; Cocek A; Sanitrák J
    Electromagn Biol Med; 2009; 28(1):1-14. PubMed ID: 19337890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte-adherence inhibition: a specific assay of cell-mediated immunity dependent on lymphokine-mediated collaboration between T lymphocytes.
    Powell AE; Sloss AM; Smith RN
    J Immunol; 1978 Jun; 120(6):1957-66. PubMed ID: 77883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
    Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
    Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAI reactivity in rats immunized with tumor cells.
    Pham Manh Hung ; Kalafut F; Novotná L; Koníková E
    Neoplasma; 1980; 27(4):373-7. PubMed ID: 7005699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of leukocyte adherence inhibition test to study the cell mediated antitumour immunity in cancer patients.
    Shirodkar SR; Gangal SG
    Indian J Med Res; 1979 Jul; 70():88-96. PubMed ID: 387584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.